
Enlivex Therapeutics Ltd. ENLV
€ 0.71
-13.24%
Geschäftsbericht 2025
hinzugefügt 11.04.2026
Enlivex Therapeutics Ltd. DPO 2011-2026 | ENLV
DPO Jährlich Enlivex Therapeutics Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 193 | 106 | 18.4 | 368 | 1.03 K | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.03 K | 18.4 | 344 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Esperion Therapeutics
ESPR
|
7.93 K | $ 2.18 | 0.46 % | $ 453 M | ||
|
Evogene Ltd.
EVGN
|
62.6 | $ 0.8 | -1.0 % | $ 27.9 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 20.93 | 2.75 % | $ 978 M | ||
|
Halozyme Therapeutics
HALO
|
24.8 | $ 66.3 | -2.24 % | $ 7.95 B | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Harmony Biosciences Holdings
HRMY
|
28.9 | $ 28.79 | -0.35 % | $ 1.66 B | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Akebia Therapeutics
AKBA
|
168 | $ 1.43 | 2.14 % | $ 368 M | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 4.17 | 2.08 % | $ 446 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 24.01 | -0.83 % | $ 3.05 B | ||
|
Incyte Corporation
INCY
|
200 | $ 94.32 | -1.82 % | $ 18.4 B | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
4.06 K | $ 32.28 | 0.12 % | $ 2.14 B | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.47 | -1.34 % | $ 391 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.57 | 0.78 % | $ 16.1 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B |